Curaxys obtains financing for the purchase of equipment with the help granted by Innplanta 2012
Curaxys SL. is the unique Spanish biotechnology company that researches, develops, produces and commercializes biosimilars in a single integrated process for combating diseases of high incidence in society as breast cancer. Curaxys hires five more technologists.
Curaxys hires five more technologists with the support of the Inncorpora Program granted by the Ministry of Economy and Competitiveness.

Curaxys: the biopharmaceuticals company focused on the production of biosimilars medication.

We specialise in creating original technologies to develop new biological process useful for the production of therapeutical biological compounds: BIOSIMILARS.

Curaxys is a European biopharmaceutical company specialising in the research, development, production and commercialisation of therapeutical proteins of high add technological value thanks to its own technology which allows from the genes translation to the industrial proteins production.

CRO Services Curaxys is specialized in the development of any monoclonal antibody, being able to carry out a complete process from the generation of the cell line that produces the target protein, to the physico-chemical characterization. CuraMab®
mAb and therapeutic proteins, obtained through mammalian cell culture using the CuraMab® Platfform with CHO cell line and humans cells lines (Retine-derivated cell line, NS0 and HEK-293)

We focus on the research, production and commercialization of recombinant proteins added value through the utilization of CuraMab® with specific human cell lines
Our expression system allows us to reach of recombinant protein levels that are clearly above those currently available.
We developed a downstream technological platform on the basis of our own laboratory data.

Curaxys obtained finance through de Ministry of Science and Innovation, inside the “Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008-2011”, through Inncopora Program 2010, (files INC10-0289, INC10-0290, INC10-0291, INC10-0292)
This proyect has been financed with 543.932€ by INNPLANTA 2012, through the Spanish Ministry of Economy and Competitiveness, inside the “Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica 2008-2011” (Project number INP-2012-0110-PCT-010000-ACT3) cofinanced by the European Regional Development Fund (FEDER), “Una manera de hacer Europa”)

Copyright 2012 Curaxys. All Rights Reserved
Legal Advice